Please assess the completion status of the following clinical trial:

Trial Title: Management of Hypotension In the Preterm Infant

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Gestational age at birth less than 28 completed weeks, i.e. up to and including 27 weeks and 6 days.~2. Within 72 hours of birth~3. An indwelling arterial line, either umbilical or peripheral (e.g. radial, posterior tibial), suitably calibrated and zeroed, to monitor BP with the measuring dome at the level of the infant's mid-axillary line when supine~4. A pre-trial cerebral ultrasound scan demonstrating no evidence of grade 3 or 4 haemorrhage intraventricular haemorrhage (IVH)(i.e. intraparenchymal echodensity or echolucency, with or without acquired cerebral ventriculomegaly)~5. A mean blood pressure 1 mmHg or more below a mean BP value equivalent to the gestational age in completed weeks, which persists over a 15 minute period (mean BP \< gestational age)~Exclusion Criteria:~1. Considered non-viable by attending clinicians.~2. Life-threatening congenital abnormalities including congenital heart disease (excluding patent ductus arteriosus, small atrial and/or ventricular septal defect). Infants known to require surgical treatment e.g. congenital diaphragmatic hernia, trache-oesophageal fistula, omphalocele, gastroschisis. Neuromuscular disorders. Frank hypovolaemia. Hydrops Fetalis.~3. Cranial ultrasound abnormality grade 3 IVH or more prior to enrolment

- Gender: ALL
- Minimum Age: 23 Weeks
- Maximum Age: 27 Weeks
- Healthy Volunteers: f

Study Arms:
- dextrose 5% (Type: PLACEBO_COMPARATOR): IV Infusion
- Dopamine Hydrochloride (Type: EXPERIMENTAL): IV Infusion

Based on this trial design, predict the completion outcome and termination type (if applicable).